Position in HYPR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$72,647
+$67,509 QoQ
Shares Held
53,813
+1072.9% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 81 holders
Holding Since
Jun 2023
4 quarters on record
Voting authority
Sole 34%
Shared 0%
None 66%
Common Shares in HYPR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,271,214,892 across 85 Medical Devices names. HYPR ranks #75 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
2,820,543 | $255,936,071 | |
| 2 | SYK |
Stryker Corp
|
616,745 | $194,175,995 | |
| 3 | MDT |
Medtronic plc
|
2,213,044 | $173,126,432 | |
| 4 | BSX |
Boston Scientific Corp
|
2,641,843 | $112,753,859 | |
| 5 | EW |
Edwards Lifesciences Corp
|
1,096,770 | $99,213,814 | |
| 6 | DXCM |
Dexcom Inc
|
768,165 | $51,735,912 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
755,006 | $48,327,934 | |
| 8 | STE |
STERIS plc
|
217,541 | $45,807,608 |
All Filings in HYPR
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $72,647 | 53,813 | Shares | Sole | 2026-08-12 | |
| 2023-12-31 | $5,138 | 4,588 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $9,405 | 4,588 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $9,864 | 4,588 | Shares | Sole | 2023-08-08 | |
| No filing history on record for this holder in this stock. | ||||||